On February 18, Adagio Therapeutics Inc. (ADGI) announced that its current CEO Tillman Gerngross has agreed to resign from the position. Consequently, the stock went
On January 12, Adagio Therapeutics Inc. (ADGI) provided highlights of its ADG20’s neutralizing activity against SARS-CoV2 variants. Along with this, the company also shared its
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.